• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用替代变量来反映牙齿的长期存活能力。

The use of surrogate variables to reflect long-term tooth survivability.

作者信息

Greenstein Gary

机构信息

Department of Periodontology, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.

出版信息

J Periodontol. 2005 Aug;76(8):1398-402. doi: 10.1902/jop.2005.76.8.1398.

DOI:10.1902/jop.2005.76.8.1398
PMID:16101375
Abstract

Clinical parameters used to monitor periodontal patients are usually measures of the disease process. They are considered surrogate variables because changes in their status are interpreted to have an impact on the ultimate goal of periodontal therapy, which is tooth retention. However, their ability to reflect tooth survivability has been questioned because there is a lack of long-term data to validate that stable or improved surrogates result in reduced tooth loss. Therefore, to clarify the utility of employing surrogates to reflect long-term tooth retention, a number of issues related to their use are discussed in this commentary: phraseology, benefits and shortcomings, biologic credibility, and their previous successful utilization in monitoring the effects of therapy. This commentary supports the reasonableness of using surrogates to monitor periodontal status and suggests that a combination of surrogates that represent "periodontal clinical health" should be considered a true endpoint of periodontal therapy, since this outcome provides a condition conducive to tooth retention.

摘要

用于监测牙周病患者的临床参数通常是疾病进程的测量指标。它们被视为替代变量,因为其状态的变化被解释为对牙周治疗的最终目标(即保留牙齿)有影响。然而,它们反映牙齿留存率的能力受到了质疑,因为缺乏长期数据来证实稳定或改善的替代指标会导致牙齿缺失减少。因此,为了阐明使用替代指标反映长期牙齿保留情况的效用,本评论讨论了与其使用相关的一些问题:术语、优缺点、生物学可信度以及它们以前在监测治疗效果方面的成功应用。本评论支持使用替代指标监测牙周状况的合理性,并建议将代表“牙周临床健康”的替代指标组合视为牙周治疗的真正终点,因为这一结果提供了有利于牙齿保留的条件。

相似文献

1
The use of surrogate variables to reflect long-term tooth survivability.使用替代变量来反映牙齿的长期存活能力。
J Periodontol. 2005 Aug;76(8):1398-402. doi: 10.1902/jop.2005.76.8.1398.
2
Prerequisite for treatment planning implant dentistry: periodontal prognostication of compromised teeth.种植义齿治疗计划的前提条件:患牙的牙周预后评估。
Compend Contin Educ Dent. 2007 Aug;28(8):436-46; quiz 447, 470.
3
[Guidelines for periodontal diagnosis in Belgium].
Rev Belge Med Dent (1984). 2008;63(2):59-63.
4
Surrogate endpoints and FDA's accelerated approval process.替代终点与美国食品药品监督管理局的加速批准程序。
Health Aff (Millwood). 2005 Jan-Feb;24(1):67-78. doi: 10.1377/hlthaff.24.1.67.
5
Long-term effects of supportive therapy in periodontal patients treated with fibre retention osseous resective surgery. II: tooth extractions during active and supportive therapy.纤维保留性骨切除术治疗牙周炎患者支持性治疗的长期效果。II:积极治疗期和支持性治疗期的拔牙情况
J Clin Periodontol. 2007 Apr;34(4):342-8. doi: 10.1111/j.1600-051X.2007.01052.x. Epub 2007 Feb 23.
6
Tooth loss in periodontally treated patients: a long-term study of periodontal disease and root caries.牙周治疗患者的失牙情况:牙周病和根面龋的长期研究。
J Clin Periodontol. 2012 Jan;39(1):73-9. doi: 10.1111/j.1600-051X.2011.01811.x. Epub 2011 Nov 7.
7
Overview of efficacy outcome variables for the evaluation of periodontal disease treatment.用于评估牙周病治疗效果的疗效结果变量概述。
J Int Acad Periodontol. 2005 Oct;7(4 Suppl):139-46.
8
The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance.菌斑控制计划对成年人牙齿丧失、龋齿和牙周疾病的长期影响。30年维护后的结果。
J Clin Periodontol. 2004 Sep;31(9):749-57. doi: 10.1111/j.1600-051X.2004.00563.x.
9
Treatment planning for implants versus tooth retention: a contemporary dilemma.种植修复与牙齿保留的治疗计划:当代的两难困境。
Dent Today. 2001 Jun;20(6):47-50.
10
Reasons for rejection of patient-reported outcome label claims: a compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006-2010.患者报告结局标签主张被拒原因:基于对 2006-2010 年间新分子实体和生物制品许可申请中患者报告结局使用情况的审查得出的综合报告。
Value Health. 2012 May;15(3):443-8. doi: 10.1016/j.jval.2012.01.010.

引用本文的文献

1
A multilevel analysis of a randomized clinical trial comparing adjunctive moxifloxacin versus amoxicillin/metronidazole for the treatment of aggressive periodontitis.一项随机临床试验的多水平分析,比较辅助使用莫西沙星与阿莫西林/甲硝唑治疗侵袭性牙周炎的效果。
Dent Res J (Isfahan). 2021 Jun 22;18:44. eCollection 2021.
2
Success of supportive periodontal therapy in periodontitis patients - A retrospective analysis.支持性牙周治疗在牙周炎患者中的疗效 - 回顾性分析。
Int J Dent Hyg. 2022 May;20(2):318-327. doi: 10.1111/idh.12521. Epub 2021 Aug 4.
3
Clinical Factors Influencing the Efficacy of Systemic Moxifloxacin in the Therapy of Patients With Generalized Aggressive Periodontitis: A Multilevel Analysis From a Clinical Trial.
影响全身应用莫西沙星治疗广泛侵袭性牙周炎患者疗效的临床因素:一项临床试验的多水平分析
Glob J Health Sci. 2015 Jun 25;8(3):80-8. doi: 10.5539/gjhs.v8n3p80.
4
Prognostic factors in periodontal therapy and their association with treatment outcomes.牙周治疗中的预后因素及其与治疗结果的关联。
World J Clin Cases. 2014 Dec 16;2(12):822-7. doi: 10.12998/wjcc.v2.i12.822.